An inconvenient hurdle in the practice of nanomedicine is the protein corona, a spontaneous
collection of biomolecular species by nanoparticles in living systems. The protein corona is …

Nanoparticle (NP)-based therapeutics have ushered in a new era in translational medicine.
However, despite the clinical success of NP technology, it is not well-understood how NPs …

The nanomaterial–protein “corona” is a dynamic entity providing a synthetic–natural
interface mediating cellular uptake and subcellular distribution of nanomaterials in biological …

Combined therapeutic strategies hold promises in augmenting antigen release to enhance
anti-tumor immunity, which have garnered attention in numerous scholarly reviews. Beyond …

The chirality of nanomaterials (nanoparticles, NPs) can influence their interaction with cells
and biological systems. However, how chirality can exert impact on the immune response …

A biomolecular coating, or biocorona, forms on the surface of engineered nanomaterials
(ENMs) immediately as they enter biological or environmental systems, defining their …

Graphene, attributable to its exceptional electrical, chemical, physical, mechanical, thermal,
structural, and optical characteristics, has evolved into a remarkable and revolutionary …

Extravasation is the first step for nanomedicines in circulation to reach targeted solid tumors.
Traditional nanomedicines have been designed to extravasate into tumor interstitium …

Abstract Two-dimensional (2D) materials such as the graphene-based materials, transition
metal dichalcogenides, transition metal carbides and nitrides (MXenes), black phosphorus …

Ferroptosis has recently emerged as a non-apoptotic form of programmed cell death and
promising target for anticancer treatment. However, it is challenging to discover ferroptosis …